Director/PDMR Shareholding
Updated : 14:36
5 November 2018
Spire Healthcare Group plc (the "Company")
Acquisition of Spire Healthcare shares by Simon Rowlands
Over the course of 2 and 5 November 2018, Simon Rowlands purchased 200,000 ordinary shares in the Company at an average price of 132.08 pence each.
Following this announcement Simon Rowlands holds a total of 528,516 ordinary shares in the Company. The shares are held through a nominee.
Enquiries:
Antony Mannion
Director, Investor Relations
0800 169 1777
The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Simon Rowlands | |
2 | Reason for the notification | ||
a) | Position/status | Non Executive Director | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Spire Healthcare Group plc | |
b) | LEI | 213800IBJPW3SE2RA350 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each | |
b) | Nature of the transaction | Purchase of 200,000 ordinary shares at 132.08 pence each | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
132.08 pence | 200,000 | ||
d) | Aggregated information - Aggregated volume - Price | As above | |
e) | Date of the transaction | 2018-11-02 and 2018-11-05 | |
f) | Place of the transaction | XLON |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.